Pluripotent stem cell therapy in ischemic cardiovascular disease

Acta Cardiologica Sinica

Volumn 30, Issue 5, 2014, Pages 365-374

  Chao, Ting Hsing ^a   Chen, I Chih ^b   Tseng, Shi Ya ^a,c   Li, Yi Heng ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b TAINAN MUNICIPAL HOSPITAL   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Embryonic stem cells; Induced pluripotent stem cells; Limb ischemia; Myocardial infarction

Indexed keywords

BIOENGINEERING; CELL DIFFERENTIATION; CELL LINEAGE; CELL SURVIVAL; CELLS; CONTAMINATION; EMBRYOID BODY; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; EXCITATION CONTRACTION COUPLING; FEEDER CELL; GENE EXPRESSION; GENETIC ENGINEERING; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART PERFORMANCE; HINDLIMB; HUMAN; IMMUNOGENICITY; ISCHEMIC HEART DISEASE; LIMB ISCHEMIA; LIMB PERFUSION; MICROVASCULATURE; MONOLAYER CULTURE; NONHUMAN; PERICYTE; PHENOTYPE; PLURIPOTENT STEM CELL; REVIEW; SAFETY; SOMATIC CELL; STEM CELL; STEM CELL CULTURE; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; VASCULAR STEM CELL;

EID: 84907273486     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Chao TH, Tseng SY, Li YH, et al. A novel vasculo-angiogenic effect of cilostazol mediated by cross-talk between multiple signalling pathways including the ERK/p38 MAPK signaling transduction cascade. Clin Sci (Lond) 2012;123:147-59.
2. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275: 964-7.
3. Chao TH, Tseng, SY, Chen IC, et al. Cilostazol enhances mobilization and proliferation of endothelial progenitor cells and collateral formation by modifying vasculo-angiogenic biomarkers in peripheral arterial disease. Int J Cardiol 2014;172:371-4.
4. Yamahara K, Itoh H. Potential use of endothelial progenitor cells for regeneration of the vasculature. Ther Adv Cardiovasc Dis 2009;3:17-27.
5. Sen S, McDonald SP, Coates PT, Bonder CS. Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease. Clin Sci (Lond) 2011;120:263-83.
6. Wang CH, Huang PH, Chen JW, et al. Clinical application of endothelial progenitor cell: are we ready? Acta Cardiol Sin 2013;29: 479-87.
7. Capogrossi MC. Cardiac stem cells fail with aging: a new mechanism for the age-dependent decline in cardiac function. Circ Res 2004;94:411-3.
8. Fadini GP, Sartore S, Albiero M, et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 2006;26:2140-6.
9. Wang WE, Chen X, Houser SR, Zeng C. Potential of cardiac stem/progenitor cells and induced pluripotent stem cells for cardiac repair in ischaemic heart disease. Clin Sci (Lond) 2013; 125:319-27.
10. Yamahara K, Sone M, Itoh H, et al. Augmentation of neovascularization [corrected] in hindlimb ischemia by combined transplantation of human embryonic stem cells-derived endothelial and mural cells. PLoS One 2008;3:e1666.
11. Yamashita J, Itoh H, Hirashima M, et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000;408:92-6.
12. Sone M, Itoh H, Yamahara K, et al. Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Arterioscler Thromb Vasc Biol 2007;27:2127-34.
13. Kehat I, Kenyagin-Karsenti D, Snir M, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001;108: 407-14.
14. Kastenberg ZJ, Odorico JS. Alternative sources of pluripotency: science, ethics, and stem cells. Transplant Rev (Orlando) 2008; 22:215-22.
15. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-76.
16. Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007; 448:318-24.
17. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007;448: 313-7.
18. Zhang J, Wilson GF, Soerens AG, et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 2009;104:e30-41.
19. Rufaihah AJ, Huang NF, Jamé S, et al. Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscler Thromb Vasc Biol 2011;31:e72-9.
20. Araki R, Uda M, Hoki Y, et al. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature 2013;494:100-4.
21. Suzuki H, Shibata R, Kito T, et al. Comparative angiogenic activities of induced pluripotent stem cells derived from young and old mice. PLoS One 2012;7:e39562.
22. Roden DM, Hong CC. Stem cell-derived cardiomyocytes as a tool for studying proarrhythmia: a better canary in the coal mine? Circulation 2013;127:1641-3.
23. Li Z, Han Z, Wu JC. Transplantation of human embryonic stem cell-derived endothelial cells for vasculardiseases. J Cell Biochem 2009;106:194-9.
24. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282: 1145-7.
25. Levenberg S, Golub JS, Amit M, et al. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2002;99:4391-6.
26. Kane NM, Meloni M, Spencer HL, et al. Derivation of endothelial cells from human embryonic stem cells by directed differentiation: analysis of microRNA and angiogenesis in vitro and in vivo. Arterioscler Thromb Vasc Biol 2010;30:1389-97.
27. Huang NF, Niiyama H, Peter C, et al. Embryonic stem cell-derived endothelial cells engraft into the ischemic hindlimb and restore perfusion. Arterioscler Thromb Vasc Biol 2010;30:984-91.
28. Li Z, Suzuki Y, Huang M, et al. Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells 2008;26:864-73.
29. Kano MR, Morishita Y, Iwata C, et al. VEGF-A and FGF-2 syner-gistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling. J Cell Sci 2005;118: 3759-68.
30. Park SW, Jun Koh Y, Jeon J, et al. Efficient differentiation of human pluripotent stem cells into functional CD34+ progenitor cells by combined modulation of the MEK/ERK and BMP4 signaling pathways. Blood 2010;116:5762-72.
31. Yang F, Cho SW, Son SM, et al. Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles. Proc Natl Acad Sci USA 2010;107:3317-22.
32. Freund C, Mummery CL. Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models. J Cell Biochem 2009;107:592-9.
33. Mummery C, Ward-van Oostwaard D, Doevendans P, et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 2003;107:2733-40.
34. Fernandes S, Naumova AV, Zhu WZ, et al. Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. J Mol Cell Cardiol 2010;49:941-9.
35. Bin Z, Sheng LG, Gang ZC, et al. Efficient cardiomyocyte differentiation of embryonic stem cells by bone morphogenetic protein-2 combined with visceral endoderm-like cells. Cell Biol Int 2006;30:769-76.
36. Yang L, Soonpaa MH, Adler ED, et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 2008;453:524-8.
37. Caspi O, Huber I, Kehat I, et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol 2007; 50:1884-93.
38. Ebelt H, Jungblut M, Zhang Y, et al. Cellular cardiomyoplasty: improvement of left ventricular function correlates with the release of cardioactive cytokines. Stem Cells 2007;25:236-44.
39. van Laake LW, Passier R, Monshouwer-Kloots J, et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res 2007;1:9-24.
40. van Laake LW, Passier R, den Ouden K, et al. Improvement of mouse cardiac function by hESC-derived cardiomyocytes correlates with vascularity but not graft size. Stem Cell Res 2009; 3:106-12.
41. Li Z, Wilson KD, Smith B, et al. Functional and transcriptional characterization of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction. PLoS One 2009;4:e8443.
42. Xiong Q, Hill KL, Li Q, et al. A fibrin patch-based enhanced delivery of human embryonic stem cell-derived vascular cell transplantation in a porcine model of postinfarction left ventricular remodeling. Stem Cells 2011;29:367-75.
43. Xiong Q, Ye L, Zhang P, et al. Bioenergetic and functional consequences of cellular therapy: activation of endogenous cardiovascular progenitor cells. Circ Res 2012;111:455-68.
44. Cao F, Sadrzadeh Rafie AH, Abilez OJ, et al. In vivo imaging and evaluation of different biomatricesfor improvement of stem cell survival. J Tissue Eng Regen Med2007;1:465-8.
45. Laflamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007; 25:1015-24.
46. Lesman A, Gepstein L, Levenberg S. Vascularization shaping the heart. Ann N Y Acad Sci 2010;1188:46-51.
47. Fujita J, Itabashi Y, Seki T, et al. Myocardial cell sheet therapy and cardiac function. Am J Physiol Heart Circ Physiol 2012;303: H1169-82.
48. Moon SH, Kim JS, Park SJ, et al. A system for treating ischemic disease using human embryonic stem cell-derived endothelial cells without direct incorporation. Biomaterials 2011;32:6445-55.
49. Kaupisch A, Kennedy L, Stelmanis V, et al. Derivation of vascular endothelial cells from human embryonic stem cells under GMP-compliant conditions: towards clinical studies in ischaemic disease. J Cardiovasc Transl Res 2012;5:605-17.
50. Narazaki G, Uosaki H, Teranishi M, et al. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 2008;118:498-506.
51. Dar A, Domev H, Ben-Yosef O, et al. Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb. Circulation 2012;125:87-99.
52. Germanguz I, Sedan O, Zeevi-Levin N, et al. Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells. J Cell Mol Med 2011;15:38-51.
53. Mauritz C, Martens A, Rojas SV, et al. Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur Heart J 2011;32:2634-41.
54. Blin G, Nury D, Stefanovic S, et al. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted non-human primates. J Clin Invest 2010;120:1125-39.
55. Nelson TJ, Martinez-Fernandez A, Yamada S, et al. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 2009;120:408-16.
56. Yan B, Abdelli LS, Singla DK. Transplanted induced pluripotent stem cells improve cardiac function and induce neovascularization in the infarcted hearts of db/db mice. Mol Pharm 2011; 8:1602-10.
57. Dai B, Huang W, Xu M, et al. Reduced collagen deposition in infarcted myocardium facilitates induced pluripotent stem cell engraftment and angiomyogenesis for improvement of left ventricular function. J Am Coll Cardiol 2011;58:2118-27.
58. Carpenter L, Carr C, Yang CT, et al. Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat. Stem Cells Dev 2012;21:977-86.
59. Zwi-Dantsis L, Huber I, Habib M, et al. Derivation and cardio-myocyte differentiation of induced pluripotent stem cells from heart failure patients. Eur Heart J 2013;34:1575-86.
60. Gu M, Nguyen PK, Lee AS, et al. Microfluidic single-cell analysis shows that porcine induced pluripotent stem cell-derived endothelial cells improve myocardial function by paracrine activation. Circ Res 2012;111:882-93.
61. Loh YH, Agarwal S, Park IH, et al. Generation of induced pluripotent stem cells from human blood. Blood 2009;113:5476-9.
62. Seki T, Yuasa S, Oda M, et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 2010;7:11-4.
63. Eminli S, Foudi A, Stadtfeld M, et al. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet 2009;41:968-76.
64. Ho PJ, Yen ML, Lin JD, et al. Endogenous KLF4 expression in human fetal endothelial cells allows for reprogramming to pluri-potency with just OCT3/4 and SOX2-brief report. Arterioscler Thromb Vasc Biol 2010;30:1905-7.
65. Koyanagi M, Iwasaki M, Rupp S, et al. Sox2 transduction enhances cardiovascular repair capacity of blood-derived meso-angioblasts. Circ Res 2010;106:1290-302.
66. Yin L, Ohanyan V, Pung YF, et al. Induction of vascular progenitor cells from endothelial cells stimulates coronary collateral growth. Circ Res 2012;110:241-52.
67. Geti I, Ormiston ML, Rouhani F, et al. A practical and efficient cellularsubstrateforthegeneration of induced pluripotentstem cells from adults: blood-derived endothelial progenitor cells. Stem Cells Transl Med 2012;1:855-65.
68. Kito T, Shibata R, Ishii M, et al. iPS cell sheets created by a novel magnetite tissue engineering method for reparative angio-genesis. Sci Rep 2013;3:1418.
69. Kawamura M, Miyagawa S, Miki K, et al. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 2012;126:S29-37.
70. Malecki M. Improved targeting and enhanced retention of the human, autologous, fibroblast-derived, induced, pluripotent stem cells to the sarcomeres of the infarcted myocardium with the aid of the bioengineered, heterospecific, tetravalent antibodies. J Stem Cell Res Ther 2013;3:138.
71. Hu K, Yu J, Suknuntha K, et al. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood 2011; 117:e109-19.
72. Chou BK, Mali P, Huang X, et al. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res 2011;21: 518-29.
73. Burridge PW, Thompson S, Millrod MA, et al. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One 2011;6:e18293.
74. Narsinh K, Narsinh KH, Wu JC. Derivation of human induced pluripotent stem cells for cardiovascular disease modeling. Circ Res 2011;108:1146-56.
75. Margariti A, Winkler B, Karamariti E, et al. Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels. Proc Natl Acad Sci USA 2012;109:13793-8.
76. Ieda M, Fu JD, Delgado-Olguin P, et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010;142:375-86.
77. Qian L, Huang Y, Spencer CI, et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012;485:593-8.
78. Li J, Huang NF, Zou J, et al. Conversion of human fibroblasts to functional endothelial cells by defined factors. Arterioscler Thromb Vasc Biol 2013;33:1366-75.
79. Hussein SM, Batada NN, Vuoristo S, et al. Copy number variation and selection during reprogramming to pluripotency. Nature 2011;471:58-62.
80. Abyzov A, Mariani J, Palejev D, et al. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature 2012;492:438-42.